John Niederhuber's most recent trade in Aptevo Therapeutics Inc was a trade of 7,200 Restricted Stock Unit done . Disclosure was reported to the exchange on Aug. 6, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Aptevo Therapeutics Inc | John Niederhuber | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Aug 2025 | 7,200 | 7,200 | - | - | Restricted Stock Unit | |
| Aptevo Therapeutics Inc | John Niederhuber | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2025 | 1 | 0 | - | - | Restricted Stock Unit | |
| Aptevo Therapeutics Inc | John Niederhuber | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2025 | 1 | 1 (0%) | 0% | - | Common Stock | |
| Aptevo Therapeutics Inc | John Niederhuber | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 925 | 925 | - | - | Restricted Stock Unit | |
| Aptevo Therapeutics Inc | John Niederhuber | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2024 | 81 | 217 (0%) | 0% | - | Common Stock | |
| Aptevo Therapeutics Inc | John Niederhuber | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2024 | 81 | 0 | - | - | Restricted Stock Unit | |
| Aptevo Therapeutics Inc | John Niederhuber | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2024 | 7 | 0 | - | - | Restricted Stock Unit | |
| Aptevo Therapeutics Inc | John Niederhuber | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2024 | 7 | 136 (0%) | 0% | - | Common Stock | |
| Aptevo Therapeutics Inc | John Niederhuber | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Aug 2023 | 3,571 | 5,682 (0%) | 0% | - | Common Stock | |
| Aptevo Therapeutics Inc | John Niederhuber | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Aug 2023 | 3,571 | 0 | - | - | Restricted Stock Unit | |
| Aptevo Therapeutics Inc | John Niederhuber | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 3,571 | 3,571 | - | - | Restricted Stock Unit | |
| Aptevo Therapeutics Inc | John Niederhuber | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2023 | 297 | 2,111 (0%) | 0% | - | Common Stock | |
| Aptevo Therapeutics Inc | John Niederhuber | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2023 | 297 | 298 | - | - | Restricted Stock Unit | |
| Aptevo Therapeutics Inc | John Niederhuber | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Aug 2022 | 3,571 | 3,571 | - | - | Restricted Stock Unit | |
| Aptevo Therapeutics Inc | John Niederhuber | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2021 | 2,678 | 2,678 | - | - | Stock Option (right to buy) | |
| Aptevo Therapeutics Inc | John Niederhuber | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2021 | 893 | 893 | - | - | Restricted Stock Unit |